InsidersTradesSigma
Track the 科拓生物 stock price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 科拓生物 has published 6 public disclosures. Market capitalisation: €3.4bn. The latest transaction was reported on 11 December 2025 (Sale). Among the most active insiders: 乔向前. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,503 of 29,064 companies
52.1
score / 100
Value30
Quality75
FCF yld-5.0%
Earn yld2.8%
EV/EBITDA25.0x
ROE4.9%
Gross mgn52%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 December 2025
Declarations6 total
6 of 6 declarations
关于 科拓生物
科拓生物是一家专注于开发生物制药解决方案的健康和制药领域的公司。它在 XSHE 市场上市。